Feb 5 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 42.37 46.30 57.50
(-8.5 pct) (-1.9 pct) (-4.8 pct)
Operating 3.86 3.38 4.30
(+14.0 pct) (+10.5 pct) (+5.0 pct)
Recurring 3.54 3.09 3.90
(+14.6 pct) (+9.5 pct) (+0.5 pct)
Net 3.69 2.34 3.70
(+57.5 pct) (-19.3 pct) (+26.5 pct)
EPS 79.83 yen 49.98 yen 80.23 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T